578 Results (Page 21 of 24)
Canada Markets Research Reports
Canada Robotic Surgery Services Market Analysis
Canada's Robotic Surgery Service market size was valued at $343Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 19.30% % from 2022 to 2030 and will reach $1408 Bn in 2030. The robotic surgery service market will grow due to robotic surgery technology having made complex surgical procedures more accessible, especially in rural areas where access to specialized surgeons may be limited. The market is segmented by product and service type, application type, and end user. Some of the major players are Titan Medical Inc (CAN), HSS Global Technologies Inc (CAN), TransEnterix, Inc (CAN), and others.
Canada Healthcare Claims Management Market Analysis
Canada's healthcare claims management market is likely to grow at a CAGR of 23.4% from a market size of $2.13 Bn in 2022 to $11.48 Bn in 2030. The rise in research and development expenditure in healthcare along with the new technological advancements and the increasing trend of automation in healthcare acts as a growth factor for the market. This report is segmented by component, type, delivery mode, and by end user. Some key players in this market include Accenture, Allscripts, Cerner, AthenaHealth, McKesson, IBM Corporation, and others.
Canada Dental Care Market Analysis
Canada's dental care market was valued at $2.87 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $4.72 Bn in 2030. One of the main reasons propelling the growth of this market demand for primary and postoperative care of higher quality, technological advancements and rising incidence of tooth decay among younger generations. The market is segmented by product, age group, and by sales services. Some key players in this market are Dentalcorp Holdings Ltd., 123Dentist, Altima Dental Canada Holdings Inc., Canadian Orthodontics Partners (COP), Teeth First Dental, and MCA Dental Group Limited.
Canada Radiotherapy Market Analysis
Canada radiotherapy market is likely to grow at a CAGR of 6% from a market size of $552.8 Mn in 2022 to $881 Mn in 2030. The rising incidence of cancer and the technological advancements in radiotherapy acts as a market growth driver. This report is segmented by type, technology, application, and by end user. Some key players in this market include Siemens Healthineers, Elekta Accuray Incorporated, Hitachi, IsoRay, Zeiss group, and others.
Canada Liver Diseases Therapeutics Market Analysis
Canada's liver disease therapeutics market is likely to grow at a CAGR of 5.7% from a market size of $1.84 Bn in 2022 to $2.87 Bn in 2030. The increase in alcohol consumption along with the change in lifestyle and increasing geriatric population acts as a market growth driver. This report is segmented by treatment type, disease type, and by distribution channel. Some key players in this market include AbbVie, Novartis, Bristol-Myers & Squibb, Merck, Roche, Eli Lilly, and others.
Canada Cardiovascular Diseases Therapeutics Market Analysis
Canada's cardiovascular disease therapeutics market is likely to grow at a CAGR of 7.22% from a market size of $13.01 Bn in 2022 to $22.72 Bn in 2030. Rising cardiovascular disease prevalence and growing R&D are the major market driver. This report is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end users. Some key players in this market include Johnson and Johnson, Gilead, AstraZeneca, Novartis, Roche, Merck, Pfizer, and others.
Canada Cancer Immunotherapy Market Analysis
Canada's cancer immunotherapy market is likely to grow at a CAGR of 7.1% from a market size of $9 Bn in 2022 to $15.58 Bn in 2030. Rising cancer prevalence and growing adoption of immunotherapy are the major market driver. This report is segmented by type, application, and by distribution channel. Some key players in this market include Johnson and Johnson, Eli Lilly, Novartis, Roche, Merck, Pfizer, and others.
Canada Liver Cancer Therapeutics Market Analysis
Canada's liver cancer therapeutics market is likely to grow at a CAGR of 17.6% from a market size of $234 Mn in 2022 to $857 Mn in 2030. The increase in awareness among the people regarding the disease and the increasing prevalence of the disease drives the market growth This report is segmented by treatment, type, equipment, route of administration, and the end user. Some key players in this market include Bayer, Bristol-Myers & Squibb, Pfizer, Merck, Roche, Eli Lilly, and others.
Canada Connected Healthcare Market Analysis
Canada connected healthcare market is likely to grow at a CAGR of 28.4% from a market size of $5.309 Bn in 2022 to $39.221 Bn in 2030. A healthcare management system called connected healthcare uses technology to deliver medical services remotely. The utilization of mHealth tools, mHealth services, and e-prescription are all included. The market is expected to rise as a result of factors like expanding healthcare-related research, improved interoperability, digital data management, and active government backing. This report is segmented by type, function type, application type, and by the end user. Some key players in this market include Allscripts, Cerner, Philips, McKesson, IBM Corporation, and others.
Canada Healthcare Financial Analytics Market Analysis
The Canada Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Canada’s Healthcare Financial Analytics market will grow as the rising cost of healthcare in Canada is driving the need for financial analytics solutions that can help healthcare organizations manage and optimize their spending. The key market players are IBM Watson Health, Healthtech Consultants, MedeAnalytics, McKesson, and others.
Canada Anemia Drugs Market Analysis
Canada's Anemia drugs market was valued at $1.28 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.9% from 2022 to 2030 and will reach $2.53 Bn in 2030. One of the main reasons propelling the growth of this market is introduction of newer technologies, aging population. The market is segmented by type, drug and distribution channel. Some key players in this market are, Amgen, Roche, Takeda Pharmaceutical, Sanofi, and Novartis among others.
Canada Patient Engagement Solutions Market Analysis
The Canada patient engagement solutions market is projected to grow from $1.36 Bn in 2022 to $3.42 Bn by 2030, registering a CAGR of 12.2% during the forecast period of 2022 - 2030. The main factors driving the growth would be digital health initiatives, increasing healthcare costs and provider adoption. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include Telus Health, WELL Health Technologies, NexJ Health, SeamlessMD and QoC Health.
Canada Artificial Intelligence (AI) in Diagnostics Market Analysis
Canada's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $0.08 Bn in 2022 to $0.88 Bn by 2030, registering a CAGR of 35% during the forecast period of 2022 - 2030. The market will be driven by a growing burden on the healthcare system and increasing investment in AI R&D and the formation of a robust AI ecosystem in Canada. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Imagia.
Canada Palliative Care Market Analysis
The Canada Palliative care market is projected to grow from $1.05 Bn in 2022 to $1.94 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-2030. The main factors driving the growth would be increasing funding for research and development, integration with other healthcare services, government support, and the aging population. The market is segmented by drug type and by disease. Some of the major players include Bayshore HealthCare, Extendicare, Revera, Sienna Senior Living, and Equinoxe life care.
Canada Acne Therapeutics Market Analysis
The high incidence of acne in Canada and growing awareness about the treatments associated with acne are the main market drivers propelling the growth of the Canada acne therapeutics market from $802 Mn in 2022 to $1,348 Mn in 2030 with a CAGR of 6.7% for the year 2022-2030. The market is segmented by treatment, route of administration, age group, and by distribution channel. The major competitors in the Canada acne therapeutics market are Amgen, Apotex, and Teva Pharmaceuticals.
Canada Rheumatology Drugs Market Analysis
The Canada Rheumatology Drugs Market is projected to grow from $4.884 Bn in 2022 to $6.091 Bn by 2030, registering a CAGR of 2.80% during the forecast period of 2022 – 2030. The Canada rheumatology drugs market is a growing market driven by the increasing incidence of rheumatoid arthritis and other rheumatic diseases and the growing elderly population. The key players in the Canada Rheumatology Drugs market include Pfizer, Roche Holding, Sanofi, Novartis International, Merck, and AbbVie.
Canada Neurology Devices Market Analysis
Canada's Neurology Device Market size is at around $1.01 Bn in 2022 and is projected to reach $ 1.84 Bn in 2030, exhibiting a CAGR of 7.8% during the forecast period. Canada suffers from a major burden of neurology diseases and the market is well-captured by players like Medtronics, B Braun, Penumbra, and Integra LifeSciences. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.
Canada HIV Therapeutics Market Analysis
By 2030, it is anticipated that the Canada HIV therapeutics market will reach a value of $1.4 Bn from $1.1 Bn in 2022, growing at a CAGR of 2.7% during 2022-2030. The market is primarily dominated by local players such as Trillium Therapeutics, AbCellera Biologics, and Aptevo Therapeutics. The market is driven by innovation in research and development, increasing prevalence, and good governance. The HIV therapeutics market in Canada is segmented by type, product, and geography, end user, and distribution channel.
Canada Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Canada Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Orphan Diseases Drugs Market, offering unmatched value, accuracy and expert insights.
Canada Women's Health Market Analysis
The Canada Women’s Health Market is projected to grow from $3.195 Bn in 2022 to $4.649 Bn by 2030, registering a CAGR of 4.80% during the forecast period of 2022 - 2030. As more women become aware of the importance of taking care of their health and the availability of new and innovative products and technologies, the demand for women's health products and services is increasing. Some key players in the Canada Women's Health market include Shoppers Drug Mart, Rexall, London Drugs, Well.ca, Jean Coutu, Pharmasave, Uniprix, Lawtons Drugs, Proxim, and IDA Pharmacy.
Canada Breast Cancer Therapeutics Market Analysis
The Canada breast cancer therapeutics market size is valued at $1.45 Bn in 2022 and is estimated to expand at a compound annual growth rate of 12.9% from 2022 to 2030 and will reach $3.84 Bn in 2030 and this rise is attributed to the novel therapies for curing breast cancer and increasing research and development activities in Canada. The market is segmented by therapy, by cancer type and by distribution channel. Some of the leading companies in the market are Johnson & Johnson Services Inc., Pfizer Inc., AbbVie Inc., etc.
Canada Over The Counter (OTC) Drugs Market Analysis
Over the Counter (OTC) drugs market in Canada is very fragmented, and the market size is expected to increase from $13.6 Bn in 2022 to $23.6 Bn in 2030, with a CAGR of 7.1%. The Canada OTC industry analysis by Insights10 recognizes the increasing approval rates and the switch from prescription drugs to OTC drugs as major market drivers. The OTC market in Canada is segmented by category and by distribution channels. Pfizer, GlaxoSmithKline, Boiron SA are some of the leading players in the OTC market.
Canada Dermatology Drugs Market Analysis
The Canada dermatology drugs market has seen a significant boost of about $1.36 Bn exhibiting a CAGR of 10.8% for the year 2022 and is estimated to grow to $3.08 Bn in 2030. The increasing prevalence of skin diseases and the rise in demand for cosmetic procedures are responsible for the growth in Canada Dermatology Drugs Market. The report is segmented by indication type, product type, and by end-use type. Merck, Abbvie Inc., and Amgen are some key market players in Canada Dermatology Drugs Market.
Canada Neurology Clinical Trials Market Analysis
This report presents a strategic analysis of the Canada Neurology Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada Neurology Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Canada eHealth Market Analysis
This report presents a strategic analysis of the Canada eHealth Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Canada eHealth Market, offering unmatched value, accuracy and expert insights.
